ERBB2 and triple-negative breast carcinoma: Their study categorized BC into 4 different molecular subtypes, which are luminal A, luminal B, human epidermal growth factor receptor 2 (HER2) enriched and basal-like triple negative breast cancer (TNBC) (Table 1) [69,73].